1.Associated factors to lower renal glomerular filtration rate in chronic hepatitis C patients
Gantogtokh D ; Batbold B ; Burmaajav B
Mongolian Medical Sciences 2022;201(3):13-19
Introduction:
Studies have shown that hepatitis C virus (HCV) infection not only causes hepatitis, but also pathological changes in other organ systems. Therefore, it is necessary to study the relationship between chronic HCV and chronic kidney disease.
Objective :
To determine the factors influencing renal glomerular function in chronic hepatitis C patients
Materials and methods:
Patients with chronic hepatitis C virus were referred to Third Central Hospital, Tegsh Huslen Medical Center, two regional 2020 from August to October. Data on morbidity of patients with chronic hepatitis C were analyzed. The results were processed using SPSS-23 software. Statistical probabilities were determined by checking whether there were statistically significant differences between the groups, using logistic regression analysis and chi-square methods.
Results :
There were 54 (46.9%) individuals whose renal glomerular filtration rate was reduced to less than 90 ml/min. In a linear regression analysis, a decrease in renal glomerular filtration rate with age was a significant correlation. Renal glomerular filtration rate is decreased in 37% patients by age-related manner (r2 = 0.37). To determine other causes, no significant correlations were observed when grouped by diabetes, cirrhosis, BMI, and hepatic steatosis (p>0.005). The older age of the patient and the high blood pressure were at 6.4 times higher risk to decrease the glomerular filtration rate in patients with chronic hepatitis C (OR 6.4 (95% CI 1.3-31.4), p=0.021) than the patients who have young age and normal blood pressure by multiple logistic regression analysis.
Conclusion
The age of the patient and high blood pressure are contributing factors to the decline in the incidence of low glomerular filtration rate in patients with chronic hepatitis C.
2.Assessment of renal function in chronic hepatitis C patients
Gantogtokh D ; Batsukh B ; Batbold B ; Burmaajav B
Mongolian Medical Sciences 2023;204(2):3-13
Background:
The association between hepatitis C virus (HCV) infection and chronic kidney disease (CKD) still
remains controversial. We aimed to investigate whether HCV really affects renal function, and to
analyze the association between clinical effects of CHC and decreased kidney function (assessed by
glomerular filtration rate (eGFR) level).
Aim:
Study of renal dysfunction in chronic hepatitis C virus infection
Materials and Methods:
An estimated 222 patients with HCV infection and 222 age- and sex-matched community-based
control individuals without HCV were enrolled (1:1, case and control ratio) in this study between from
June 2022 to March 2023. We used the modification of diet in renal diseases to calculate eGFR.
This study was approved by the review board of the Ethics Subcommittee of Ach Medical University
and followed the Declaration of Helsinki. All statistical analysis was performed with SPSS version
26.0 software (SPSS Inc., Chicago, IL, USA), and a P value < 0.05 was considered statistically
significant. Continuous variebles were presented as mean ± standard deviation, while categorical
data was represented as numbers and percentages. Independent t-tests were used to compare the
differences in parametric variables. The Mann-Whitney U test was performed to compare the follow-up
period. Pearson’s chi-squared and Fisher’s exact tests were used to compare categorical variables.
Multivariate logistic regression was used to identify the risk factors associated with recurrence.
Results:
The median age of the respondents was 40 (range 21-70). In the case group, the speed of hanging
judgment was 105.3±24.5, and in the control group, it was 118.7±18.5, which was a statistically
significant difference (p<0.05, p<0.05). It was observed that the rate of filtration of the renal is below
90 or the loss of renal function increases with age (47.50±9.3 vs 40.21±11.1; p<0.01). In order to
reduce the effect of age, when evaluating the renal function of participants over 45 years of age
in the case-control group, the HCV was 99.69 in the case group and 111.05 in the control group,
although there was an age effect on the decline in HCV in both groups, but it decreased more in the
HCV-infected group. When comparing two groups (<3.25, >3.25) with liver fibrosis degree above
and below 3.25, the higher degree of fibrosis affects the decrease in the rate of hepatic filtration (112.92±19.8 vs 105.23±27.1; p<0.01). The proportion of cryoglobulinemia was high when renal
dysfunction was beginning or when the GFR was below 90 (<90). Logistic regression analysis showed
that cryoglobulinemia had the greatest influence on the decrease in glomerular filtration rate (OR
4.22, 95% CI 1.97-9.00, p<0.05). The relationship between age and the decline in hanging judgment
speed was statistically significant and directly moderate (r=0.95, p=0.009). On the other hand, there
is a statistical relationship between gender and the decrease in the speed of hanging judgment, with
a probable and weak correlation (r=0.07, p=0.01).
Conclusion
Our study found that the patients with HCV infection are associated with a low
eGFR compared with non-HCV–infected patients. This association is consistent in age, gender,
cryoglobulinemia and liver fibrosis patients.
3.Results of determination of salidroside content in roots and rhizomes of cultivated and natural Rhodiola rosea L
Khishigjargal B ; Lkhaasuren R ; Batdorj D ; Suvdaa T ; Gantogtokh G ; Orkhon N ; Tsetsegmaa S ; Khurelbaatar L
Mongolian Medical Sciences 2021;195(1):51-55
Introduction:
Rhodiola rosea L. (R.rosea) is a popular plant in traditional medicine of the Nordic countries, Eastern
Europe, and Asia. R.rosea plants are successfully cultivated in Mongolia. The Botanical Garden of
Medicinal Plants under the “Monos” Group started to cultivate R. rosea since May 2015.
Objective:
The aim of this research was to study the salidroside contents of R.rosea collected from Zavkhan
and Khuvsgul province, Mongolia, and cultivated in the Botanical Garden of Medicinal Plants, Drug
research Institute, Monos group.
Material and Methods:
The underground parts of wild roseroot plants were collected from April to May 2020 from Jargalant
soum, Khuvsgul province, and Nomrog soum, Zavkhan province, 3-years and 4-years-old cultivated
R.rosea gathered from the Botanical Garden of Medicinal Plants in April 2020. For comparison,
4-year-old Rhodiola grenulata (R. grenulata) was ordered from Shanxi Zhendong Genuine Medicinal
Materials Development Co., Ltd, China, and used for the study. The quantity of the salidroside
constituents of the underground parts were compared and the sourcing of roseroot raw material was
evaluated. Chemical analysis of roots and rhizome of R. Rosea namely the appearance, identification,
moisture, organic impurities, mineral impurities, residue on ignition, water-soluble extractives, fresh
weight of roots, and salidroside content were determined according to the National Pharmacopoeia of
Mongolia (NPhM) 2011. Microbiological analysis was performed in accordance with the requirements
of grade 3b specified in Annex 1 of the Order No. A / 219 of the Minister of Health dated May 30,
2017 to determine the degree of microbiological purity in medicinal products of roots and rhizome
raw materials.
Result:
The content of salidroside, the main biologically active substance of R.rosea plant, was 1.57% in
samples collected from Zavkhan province, 1.45% in samples collected from Khuvsgul province, 1.7%
in samples grown in China and 0.25% for 3-years-old samples and 1.89% for 4-years-old samples grown in the Botanical Garden of Medicinal Plants, Monos group, Mongolia. In addition, these raw
materials meet the general requirements for plant raw materials and microbiological parameters.
Conclusion
Samples of underground parts of R.rosea cultivated for 4 years in the Botanical Garden of Medicinal
Plants have the highest content (1.89%) of the salidrosde. Therefore, it is suggested that the roots
and rhizomes of R.rosea planted in the future can be standardized and used as a raw materials for
medicines.